HENDERSON, Nev.--(BUSINESS WIRE)--Quertle LLC has developed the first artificial intelligence and visual analytics big data (BioAI™) platform for biomedical drug discovery. This platform combines ...
BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with ...
Quris Technologies Ltd. has inked an agreement with Merck KGaA to assess its BioAI safety prediction platform. The partnership will compare the Quris’ artificial intelligence (AI)-based platform with ...
German drugmaker Merck KGaA has reached an agreement to pilot an artificial intelligence platform developed by Quris that aims to identify potential safety problems with new therapeutic candidates as ...
Arbele, a leading innovator in biopharmaceutical and biotechnology focused on targeting cadherin-17 (CDH17), has announced a strategic collaboration in precision oncology using artificial intelligence ...
Quris Technologies Ltd. (Quris-AI) and Merck KGaA have extended their collaboration after a successful initial preclinical study of Quris-AI’s BioAI drug safety platform.
Artificial intelligence is being positioned as a catalytic force in reshaping biomanufacturing, with policymakers, scientists and industry leaders outlining a roadmap that blends computational power ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results